Human immunodeficiency virus (HIV) and hepatitis B virus (HBV) coinfection is known to accelerate liver disease progression. Whether coinfection is accompanied by a greater burden of newly documented social determinants of health (SDoH) compared with HIV or HBV monoinfection had not been clearly defined. This study used a large federated electronic health record network to evaluate incident SDoH in adults with HIV/HBV coinfection versus matched adults with HIV-only or HBV-only.
Investigators conducted a retrospective cohort study using TriNetX, a federated national health research network aggregating data from 110 U.S. healthcare organizations. The study period spanned 2010 through 2026. Adults with HIV/HBV coinfection were identified and propensity score matched to adults with HIV monoinfection and separately to adults with HBV monoinfection.
Matched cohort sizes were reported as 10,071 HIV/HBV–HIV pairs and 9,659 HIV/HBV–HBV pairs. Across matched cohorts the mean age was 47 years, 79% were male, 66% were non-White, and the median follow-up time was 3.3 years. Analyses covered a total of approximately 178,900 person-years.
The authors organized newly documented SDoH indicators using a dynamic, individual-level framework comprising four clinically recognized domains of social disadvantage:
A primary composite SDoH outcome combined newly documented indicators across these domains. Specific indicators cited in the manuscript included housing instability, food insecurity, financial insecurity, insurance instability, care disengagement, and nonadherence, among others.
Adults with HIV/HBV were propensity score matched to adults with HIV-only and separately to adults with HBV-only to balance baseline characteristics. Incidence rates, incidence proportions, and hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated to compare risk of newly documented SDoH between matched groups. Sensitivity analyses were performed; the manuscript reports that findings remained robust across these analyses.
The matched cohorts were clinically described as having a mean age of 47 years, predominance of male sex (79%), and majority non-White race/ethnicity (66%). Median follow-up for participants was 3.3 years. The combined observation time across cohorts totaled roughly 178,900 person-years.
Compared with matched adults with HIV monoinfection, adults with HIV/HBV coinfection had a higher incidence of the primary SDoH composite: 11.5% versus 9.7%. Incidence rates were 2.50 versus 1.97 per 100 person-years, and the reported hazard ratio was 1.25 (95% CI, 1.15–1.37).
Compared with matched adults with HBV monoinfection, HIV/HBV was also associated with a higher incidence of the primary SDoH composite: 11.0% versus 6.4%. Incidence rates were 2.39 versus 1.67 per 100 person-years, with a reported hazard ratio of 1.50 (95% CI, 1.35–1.67).
The study found that material vulnerability and healthcare access and engagement composites were more common among people with HIV/HBV than among either monoinfection group. Specific SDoH indicators within these domains that were increased in coinfection included:
Reported hazard ratio ranges for these indicators were 1.22–3.33 in the comparison with HIV monoinfection and 1.31–1.94 in the comparison with HBV monoinfection.
In the comparison of HIV/HBV versus HBV monoinfection, the authors additionally observed higher rates of interpersonal adversity, including primary support stressors and violence or victimization, with hazard ratio ranges reported between 1.36 and 2.16. The manuscript indicates interpersonal adversity findings were more prominent when coinfection was compared with HBV alone.
The report states that findings were robust across sensitivity analyses. The manuscript does not provide additional numerical detail about the specific sensitivity tests or their results in the abstracted text; details beyond that were not reported in the source excerpt.
In this large, multi‑center retrospective analysis using electronic health record data, HIV/HBV coinfection was associated with more newly documented social determinants of health than either HIV or HBV monoinfection. The excess burden was observed across multiple domains, particularly material vulnerability and healthcare access and engagement, and additionally interpersonal adversity in comparisons with HBV-only.
The authors frame these findings in support of dynamic, individual-level SDoH assessment for people with coinfection. Identifying incident social needs could inform clinical management and targeted interventions, recognizing the intersection between biomedical risk and social vulnerability.
Deidentified individual participant data were extracted from TriNetX. Use of these data was conducted with a waiver from WCG IRB, as reported in the manuscript. The authors declared no competing interests. Funding support listed in the manuscript included NIAID grants (5UM1AI069501 and P30AI036219). The source text did not report additional institutional limitations or detailed sensitivity analysis methods within the provided excerpt.